Gossamer Bio, Inc. (GOSS)

Gossamer Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	241	206	205	865	734	1,032
Market Cap Growth	122.41%	0.33%	-76.29%	17.78%	-28.87%	-
Enterprise Value	203	118	172	722	401	668
PE Ratio	-	-1.14	-0.89	-3.70	-3.02	-5.72
PB Ratio	9.02	3.28	16.98	7.12	2.29	2.93
P/FCF Ratio	-1.68	-1.29	-1.09	-4.54	-4.13	-6.98
P/OCF Ratio	-1.68	-1.29	-1.10	-4.58	-4.16	-7.13
EV/EBITDA Ratio	-1.47	-0.73	-0.82	-3.45	-1.77	-3.81
EV/EBIT Ratio	-1.43	-0.71	-0.80	-3.36	-1.74	-3.74
EV/FCF Ratio	-1.44	-0.74	-0.92	-3.79	-2.26	-4.52
Debt / Equity Ratio	7.72	3.33	18.44	1.50	0.56	0.11
Debt / EBITDA Ratio	-1.33	-1.29	-1.06	-0.87	-0.80	-0.21
Debt / FCF Ratio	-1.30	-1.31	-1.19	-0.96	-1.01	-0.25
Quick Ratio	6.82	5.74	5.19	8.16	13.28	10.88
Current Ratio	7.13	5.94	5.32	8.32	13.51	11.09
Interest Coverage	-12.13	-12.31	-15.53	-11.04	-18.21	-92.04
Return on Equity (ROE)	-525.70%	-944.80%	-1117.20%	-119.40%	-68.60%	-43.10%
Return on Assets (ROA)	-62.70%	-67.80%	-80.70%	-56.90%	-45.90%	-37.60%
Return on Capital (ROIC)	-76.26%	-67.58%	-93.08%	-71.14%	-46.72%	-47.77%
Earnings Yield	-71.63%	-87.42%	-111.88%	-27.06%	-33.15%	-17.47%
FCF Yield	-65.78%	-77.38%	-91.43%	-22.02%	-24.22%	-14.32%
Buyback Yield / Dilution	-137.94%	-80.46%	-13.00%	-9.24%	-25.16%	-741.53%
Total Shareholder Return	-137.94%	-80.46%	-13.00%	-9.24%	-25.16%	-741.53%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).